Stony Brook University and 10 other world-class private and academic medical centers have announced the collaboration of the New York Genome Center, one of the largest bioinformatics and genomics facilities in North America with the goal of significantly accelerating progress toward a new era of genomic research. Through this partnership, scientists and physicians from Stony Brook and other member institutions will share diverse clinical and genomic data on a scale not yet realized in order to discover the molecular underpinnings of disease, identify and validate biomarkers, and accelerate development of novel diagnostics and targeted therapeutics to improve clinical care.
Institutions collaborating with Stony Brook include Cold Spring Harbor Laboratory, Columbia University, Cornell University/Weill Cornell Medical College, Memorial Sloan-Kettering Cancer Center, Mount Sinai Medical Center, NewYork-Presbyterian Hospital, New York University/NYU School of Medicine, North Shore-LIJ Health System, The Jackson Laboratory, and The Rockefeller University. The Hospital for Special Surgery is an associate founding member.
Setting aside traditional competitiveness among nationally and internationally recognized leaders in research and medicine, these leading medical institutions, along with technology and pharmaceutical innovators, have come together behind NYGC with the goal of significantly accelerating progress toward a new era of genomic research and having a profound impact on patient care and clinical outcomes in the near future.
An independent, nonprofit consortium, NYGC will establish one of the largest genomics facilities in North America. The Center will begin operations as early as spring 2012. Its 120,000-square-foot facility, designed by Elkus Manfredi Architects, will be located in Manhattan.